Autologous stem cell transplantation in severe treatment-resistant Crohn's disease: Long-term follow-up of UK patients treated on compassionate basis

QJM: An International Journal of Medicine

Volumn 107, Issue 11, 2014, Pages 871-877

  Snowden, J A ^a,b   Ansari, A ^c   Sachchithanantham, S ^d   Jackson, G ^e   Thompson, N ^f   Lobo, A ^a   Sanderson, J ^d   Kazmi, M ^d  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c EAST SURREY HOSPITAL   (United Kingdom)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MESNA; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY; MYELOABLATIVE AGENT;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; COMPASSIONATE USE; CROHN DISEASE; DISEASE CONTROL; DISEASE FREE INTERVAL; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; MALE; MIDDLE AGED; OVARY INSUFFICIENCY; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME; UNITED KINGDOM; AUTOTRANSPLANTATION; CLINICAL TRIAL; DRUG RESISTANCE; EVALUATION STUDY; FEASIBILITY STUDY; MULTICENTER STUDY; PROCEDURES; STEM CELL TRANSPLANTATION;

ADULT; CROHN DISEASE; CYCLOPHOSPHAMIDE; DRUG RESISTANCE; FEASIBILITY STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84929657156     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcu095     Document Type: Article

References (23)

1. Caprilli R, Angelucci E, Clemente V. Recent advances in the management of Crohn's disease. Dig Liver Dis 2008; 40:709-16.
2. Jess T, Winther KV, Munkholm P, Langholz E, Binder V. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 2002; 122:1808-14.
3. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88:1818-25.
4. Cooke WT, Mallas E, Prior P, Allan RN. Crohn's disease: course, treatment and long term prognosis. Q J Med 1980; 49:363-84.
5. Canavan C, Abrams KR, Hawthorne B, Mayberry JF. Longterm prognosis in Crohn's disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff. Aliment Pharmacol Ther 2007; 25:59-65.
6. O'Hanrahan T, Irving MH. The role of home parenteral nutrition in the management of intestinal failure-report of 400 cases. Clin Nutr 1992; 11:331-6.
7. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19:643-5.
8. Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, et al. on behalf of the EBMT Autoimmune Disease (ADWP) and Paediatric Diseases (PDWP) Working Parties. Haematopoietic stem cell transplantation (HSCT) in severe auto-immune diseases (ADs): updated guidelines of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2012; 47:770-90.
9. Hough RE, Snowden JA, Wulffraat NM. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol 2005; 128:432-59.
10. Kapoor S, Wilson AG, Sharrack B, Lobo A, Akil M, Sun L, et al. Haemopoietic stem cell transplantation for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Hematology 2007; 12:179-91.
11. Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J, et al. Autologous hematopoietic stem cell transplantation (HSCT) for autoimmune diseases: an observational study on 12 years of experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases. Haematologica 2010; 95:284-92.
12. Snowden JA, Pearce RM, Lee J, Kirkland K, Gilleece M, Veys P, et al. on behalf of the BSBMT Clinical Trials Committee. Haematopoietic stem cell transplantation (HSCT) in severe autoimmune disorders: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009. Br J Haematol 2012; 157:742-6.
13. Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201:805-16.
14. Roord STA, de Jager W, Boon L, Wulffraat N, Martens A, Prakken B, et al. Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells. Blood 2008; 111:5233-41.
15. Burt RK, Craig RM, Milanetti F, Quigley K, Gozdziak P, Bucha J, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood 2010; 116:6123-32.
16. Clerici M, Cassinotti A, Onida F, Trabattoni D, Annaloro C, Della Volpe A, et al. Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn's disease. Dig Liver Dis 2011; 43: 946-52.
17. Cassinotti A, Annaloro C, Ardizzone S, Onida F, Della Volpe A, Clerici M, et al. Autologous hematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut 2008; 57:211-7.
18. Hasselblatt P, Drognitz K, Potthoff K, Bertz H, Kruis W, Schmidt C, et al. Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Aliment Pharmacol Ther 2012; 36:725-35.
19. Scimè R, Cavallaro AM, Tringali S, Santoro A, Rizzo A, Montalbano L, et al. Complete clinical remission after highdose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy. Inflamm Bowel Dis 2004; 10:892-4.
20. Hawkey C, Allez M, Ardizzone S, Clark E, Clark M, Columbel JF, et al. Clinical and endoscopic improvement following haemopoietic stem cell transplantation on behalf of the Autoimmune Disease Working Party of the EBMT (abstract). Bone Marrow Transplant 2013; 48:S44.
21. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, et al. Recommended screening and preventative practices for long-term survivors after haematopoietic cell transplantation. Bone Marrow Transplant 2012; 47:337-41.
22. Greenfield DM, Boland E, Ezaydi Y, Ross RJM, Ahmedzai SH, Snowden JA. Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively treated (transplanted) multiple myeloma. Bone Marrow Transplant 2014; 49:907-12.
23. Tailor IK, Akil M, Rennie I, Ross RJ, Snowden JA. Reconstitution Graves' disease following autologous haematopoietic stem cell transplantation (HSCT) for severe diffuse systemic sclerosis. Quart J Med 2012; 105:369-71.